COLL · Collegium Pharmaceutical Inc
United States · RS rating 27 · As of 2026-11-03
| Price | 23.73 USD |
|---|---|
| 1-day change | +0.2% |
| RS rating (overall / 1M / 3M / 12M) | 27 / 79 / 18 / 29 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 10 / 24 |
| Industry group (rank) | Medical-Generic Drugs (136) |
| EPS growth Q/Q | -45.2% |
| Sales growth Q/Q | -1.9% |
| Distance from 52-week high | +52.4% |
| Market cap (USD) | $1.0B |